• Something wrong with this record ?

Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency

D. Musalkova, E. Sticova, M. Reboun, J. Sokolova, J. Krijt, J. Honzikova, J. Gurka, M. Neroldova, T. Honzik, J. Zeman, M. Jirsa, L. Dvorakova, M. Hrebicek,

. 2018 ; 472 (6) : 1029-1039. [pub] 20180406

Language English Country Germany

Document type Journal Article

E-resources Online Full text

NLK ProQuest Central from 2003-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2011-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2003-01-01 to 1 year ago

Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder that causes recurrent and life-threatening episodes of hyperammonemia. The clinical picture in heterozygous females is highly diverse and derives from the genotype and the degree of inactivation of the mutated X chromosome in hepatocytes. Here, we describe molecular genetic, biochemical, and histopathological findings in the livers explanted from two female patients with late-onset OTC deficiency. Analysis of X-inactivation ratios by DNA methylation-based assays showed remarkable intra-organ variation ranging from 46:54 to 82:18 (average 70:30, n = 37), in favor of the active X chromosome carrying the mutation c.583G>C (p.G195R), in the first patient and from 75:25 to 90:10 (average 82:18, n = 20) in favor of the active X chromosome carrying the splicing mutation c.663+1G>A in the second patient. The X-inactivation ratios in liver samples correlated highly with the proportions of OTC-positive hepatocytes calculated from high-resolution image analyses of the immunohistochemically detected OTC in frozen sections that was performed on total area > 5 cm2. X-inactivation ratios in blood in both female patients corresponded to the lower limit of the liver values. Our data indicate that the proportion of about 20-30% of hepatocytes expressing the functional OTC protein is not sufficient to maintain metabolic stability. X-inactivation ratios assessed in liver biopsies taken from heterozygous females with X-linked disorders should not be considered representative of the whole liver.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024272
003      
CZ-PrNML
005      
20181017072103.0
007      
ta
008      
180709s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00428-018-2345-x $2 doi
035    __
$a (PubMed)29623395
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Musalkova, Dita $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic. dita.musalkova@lf1.cuni.cz.
245    10
$a Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency / $c D. Musalkova, E. Sticova, M. Reboun, J. Sokolova, J. Krijt, J. Honzikova, J. Gurka, M. Neroldova, T. Honzik, J. Zeman, M. Jirsa, L. Dvorakova, M. Hrebicek,
520    9_
$a Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder that causes recurrent and life-threatening episodes of hyperammonemia. The clinical picture in heterozygous females is highly diverse and derives from the genotype and the degree of inactivation of the mutated X chromosome in hepatocytes. Here, we describe molecular genetic, biochemical, and histopathological findings in the livers explanted from two female patients with late-onset OTC deficiency. Analysis of X-inactivation ratios by DNA methylation-based assays showed remarkable intra-organ variation ranging from 46:54 to 82:18 (average 70:30, n = 37), in favor of the active X chromosome carrying the mutation c.583G>C (p.G195R), in the first patient and from 75:25 to 90:10 (average 82:18, n = 20) in favor of the active X chromosome carrying the splicing mutation c.663+1G>A in the second patient. The X-inactivation ratios in liver samples correlated highly with the proportions of OTC-positive hepatocytes calculated from high-resolution image analyses of the immunohistochemically detected OTC in frozen sections that was performed on total area > 5 cm2. X-inactivation ratios in blood in both female patients corresponded to the lower limit of the liver values. Our data indicate that the proportion of about 20-30% of hepatocytes expressing the functional OTC protein is not sufficient to maintain metabolic stability. X-inactivation ratios assessed in liver biopsies taken from heterozygous females with X-linked disorders should not be considered representative of the whole liver.
650    _2
$a biopsie $7 D001706
650    _2
$a lidské chromozomy X $x genetika $7 D041321
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a glutaminsynthetasa $x genetika $x metabolismus $7 D005974
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a játra $x enzymologie $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ornithinkarbamoyltransferasa $x genetika $x metabolismus $7 D009954
650    _2
$a nemoc z nedostatku ornithinkarbamoyltransferázy $x genetika $7 D020163
650    _2
$a pohlavní dimorfismus $7 D012727
650    12
$a inaktivace chromozomu X $7 D049951
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sticova, Eva $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
700    1_
$a Reboun, Martin $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
700    1_
$a Sokolova, Jitka $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
700    1_
$a Krijt, Jakub $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
700    1_
$a Honzíková, Jitka $7 xx0228095 $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
700    1_
$a Gurka, Jiri $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic. Institute of Histology and Embryology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Neroldova, Magdalena $u Laboratory of Experimental Hepatology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
700    1_
$a Honzik, Tomas $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Zeman, Jiri $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Jirsa, Milan $u Laboratory of Experimental Hepatology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
700    1_
$a Dvorakova, Lenka $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
700    1_
$a Hrebicek, Martin $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic. martin.hrebicek@lf1.cuni.cz.
773    0_
$w MED00004660 $t Virchows Archiv an international journal of pathology $x 1432-2307 $g Roč. 472, č. 6 (2018), s. 1029-1039
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29623395 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20181017072601 $b ABA008
999    __
$a ok $b bmc $g 1316403 $s 1021193
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 472 $c 6 $d 1029-1039 $e 20180406 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
LZP    __
$a Pubmed-20180709

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...